|

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

RECRUITINGN/ASponsored by Johns Hopkins University
Actively Recruiting
PhaseN/A
SponsorJohns Hopkins University
Started2023-01-06
Est. completion2026-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This research is being done to compare two different methods of wound monitoring for chronic wounds: remote wound monitoring using a smartphone app and in-person wound monitoring in a clinic setting. This will be a pilot non-blinded randomized controlled feasibility trial. The investigators will enroll 120 patients with an active diabetic foot ulcer (DFU) who present to the multidisciplinary diabetic foot clinic in Baltimore, Maryland. Patients will be computer randomized 1:1 to receive wound care monitoring using remote DFU monitoring technology or standard in-person monitoring for 12 weeks.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or female, aged ≥ 18 years old
* In treatment for lower extremity wound related to diabetic foot ulcer
* Able and willing to use a smartphone to assess the wound for the duration of the study
* English language proficiency

Exclusion Criteria:

* Patients with less than 1 dressing change per week
* Patients with wound size that cannot be covered with a single app scan (out of boundary conditions include wounds that wrap around patient's entire leg)
* Patients with wounds in an inaccessible location who live without a caregiver to assist in taking wound scans

Conditions7

DiabetesDiabetes ComplicationsDiabetic FootDiabetic Foot UlcerWound HealWound LegWound; Foot

Locations1 site

Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287
Caitlin Hicks, MD410-955-5165

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.